Q & M DENTAL GROUP (SINGAPORE) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.24 SGD | 0.00% |
|
+4.35% | -5.88% |
| 04-16 | Q & M Dental Group Limited Announces Cessation of Chong Kai Chuan as Alternate Director | CI |
| 04-16 | Q & M Dental Group Limited Announces Resignation of Ang Ee Peng Raymond as Executive Director | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -5.88% | 168M | C+ | ||
| +13.70% | 80.61B | C+ | ||
| -29.20% | 70.18B | B- | ||
| +9.86% | 29.08B | C+ | ||
| -11.43% | 16.97B | B | ||
| -0.43% | 16.96B | A- | ||
| -0.31% | 15.26B | A- | ||
| +3.42% | 12.41B | A- | ||
| -30.70% | 11.95B | - | - | |
| -6.75% | 11.93B | B- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- QC7 Stock
- Ratings Q & M Dental Group (Singapore) Limited
